Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meletios Dimopoulos

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Cancer Treatment Reviews|February 2, 2016
The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studiesMadeleine Duvic, Meletios Dimopoulos
Leukemia & Lymphoma|January 19, 2008
High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?Meletios Dimopoulos, Efstathios Kastritis
Leukemia & Lymphoma|December 11, 2007
How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomideEfstathios Kastritis, Meletios Dimopoulos
Seminars in Oncology|April 30, 2003
Defining Waldenstrom's macroglobulinemiaSteven P Treon, Meletios Dimopoulos, Robert A Kyle
The Lancet. Oncology|March 3, 2022
Post-protocol therapy and informative censoring in the CANDOR study - Authors' replySaad Z Usmani, Chuang Li, Mihaela Obreja, et al.
Lipids in Health and Disease|August 2, 2011
Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13,800 patients and 23,340 controls in 19 observational studiesTheodora Psaltopoulou, Rena I Kosti, Dimitrios Haidopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendationsJoan Bladé, Meletios Dimopoulos, Laura Rosiñol, et al.
World Journal of Surgical Oncology|April 10, 2009
Treatment of early uterine sarcomas: disentangling adjuvant modalitiesFlora Zagouri, Athanasios-Meletios Dimopoulos, Stelios Fotiou, et al.
Leukemia & Lymphoma|April 26, 2013
The role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myelomaRoman Hajek, David Siegel, Robert Z Orlowski, et al.
Clinical Lymphoma|January 8, 2005
Hemophagocytic lymphohistiocytosis after chemotherapy for multiple myelomaJohn V Terrovitis, Charis Matsouka, Athanassios Anagnostopoulos, et al.
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Cancer Treatment Reviews|February 2, 2016
The safety profile of vorinostat (suberoylanilide hydroxamic acid) in hematologic malignancies: A review of clinical studiesMadeleine Duvic, Meletios Dimopoulos
Leukemia & Lymphoma|January 19, 2008
High dose therapy for light chain amyloidosis: can we reduce treatment related mortality further?Meletios Dimopoulos, Efstathios Kastritis
Leukemia & Lymphoma|December 11, 2007
How to prevent deep vein thrombosis in myeloma patients receiving thalidomide or lenalidomideEfstathios Kastritis, Meletios Dimopoulos
Seminars in Oncology|April 30, 2003
Defining Waldenstrom's macroglobulinemiaSteven P Treon, Meletios Dimopoulos, Robert A Kyle
The Lancet. Oncology|March 3, 2022
Post-protocol therapy and informative censoring in the CANDOR study - Authors' replySaad Z Usmani, Chuang Li, Mihaela Obreja, et al.
Lipids in Health and Disease|August 2, 2011
Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13,800 patients and 23,340 controls in 19 observational studiesTheodora Psaltopoulou, Rena I Kosti, Dimitrios Haidopoulos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009
Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendationsJoan Bladé, Meletios Dimopoulos, Laura Rosiñol, et al.
World Journal of Surgical Oncology|April 10, 2009
Treatment of early uterine sarcomas: disentangling adjuvant modalitiesFlora Zagouri, Athanasios-Meletios Dimopoulos, Stelios Fotiou, et al.
Leukemia & Lymphoma|April 26, 2013
The role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myelomaRoman Hajek, David Siegel, Robert Z Orlowski, et al.
Clinical Lymphoma|January 8, 2005
Hemophagocytic lymphohistiocytosis after chemotherapy for multiple myelomaJohn V Terrovitis, Charis Matsouka, Athanassios Anagnostopoulos, et al.
Pageof 12